Skip to content
Home / News |

iSpecimen Stock Up 98% on Government Selection of Covid-19 Research

ispecimen
Nigel F

Stock of iSpecimen (NASDAQ: ISPC) soared almost 100% in Monday’s premarket trading; with investors reacting to news that the company has been awarded a contract to support advanced research on Covid-19; more specifically, further data on transmission, variants, and testing validity. 

As we crawl out of the lighter end of the pandemic, investors remain incredibly active in clutching at potential lifelines. Stock like Merck and Pfizer have seen periods of strong volatility as the vaccine race continues to dominate the pharmaceutical sector, while companies like iSpecimen make their mark in an increasingly competitive space. In the last 10 months, iSpecimen has been involved in multiple research projects and health care initiatives – providing critical biospecimens for samples, swabs, saliva, and blood products. 

Christopher Ianelli, MD, Ph.D, iSpecimen CEO and Founder notes the importance of future study:

X testing X
WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
5.0
Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

“COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society’s ability to contend with future outbreaks of infectious diseases”

Adding…

“We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they’re focusing on.”

iSpecimen stock is charging forward in Monday premarket, currently recording gains of nearly 100%, soaring past an all-time high of $8.33 to trade around $9.70. In a powerful start to the trading week, ISPC stock is maintaining impressive momentum and, depending on when profit-takers step in, can continue its rally through the opening market bells. 

Should You Invest in iSpecimen Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now

See our best stocks to buy now guide
Nigel F
Nigel F
Team Member

Nigels tiefes Verständnis der Finanzmärkte basiert auf über 10 Jahren Erfahrung. Nigel wurde bisher zweimal von der FCA (Financial Conduct Authority) autorisiert und hat in der letzten Zeit eine Finanz-Brokerage Firma besessen und verkauft. Er liefert hochaktuelle Analysen und Einsichten in die Finanzmärkte und in die allgemeine Wirtschafts- und Währungspolitik des Vereinigten Königreichs, der USA, Europas und Asiens.